SolvencyTool logo
Explicações de reporte

Explicações de reporte

Início / Atos e regulamentos / Explicações de reporte
S.01.01 Content of the submission
Document
S.02.01 Balance sheet
Document
S.05.01 Prem., claims & exp. – lobs
Document
S.12.01 Life & health SLT TP
Document
S.17.01 Non-life & health NSLT TP
Document
S.23.01 Own funds
Document
S.25.01 SCR – Standard formula
Document
S.28.01 MCR – Non-composites
Document
G.01.01 Content of the submission
Document
G.02.01 Balance sheet
Document
S.01.01 Content of the submission
Document
S.02.01 Balance sheet
Document
S.05.01 Prem., claims & exp. – lobs
Document
S.12.01 Life & health SLT TP
Document
S.17.01 Non-life & health NSLT TP
Document
S.23.01 Own funds
Document
S.25.01 SCR – Standard formula
Document
S.28.01 MCR – Non-composites
Document
G.01.01 Content of the submission
Document
G.02.01 Balance sheet
Document
G.05.01 Prem., claims & exp. – lobs
Document
G.23.01 Own funds
Document
G.25.01 SCR – Standard formula
Document
SE.01.01 Content of the submission
Document
SE.02.01 Balance sheet
Document
SE.06.02 List of assets
Document
E.01.01 Deposits to cedants
Document
E.02.01 Pension entitlements
Document
E.04.01 Investment revenues and expenses
Document
G.05.01 Prem., claims & exp. – lobs
Document
G.23.01 Own funds
Document
G.25.01 SCR – Standard formula
Document
SE.01.01 Content of the submission
Document
SE.02.01 Balance sheet
Document
SE.06.02 List of assets
Document
E.01.01 Deposits to cedants
Document
E.02.01 Pension entitlements
Document
E.04.01 Investment revenues and expenses
Document

Nenhum documento encontrado

Verifique o código do modelo (por exemplo S.02.01) ou experimente um termo mais curto.

Falta algum modelo? Marcar uma demo

EIOPA Solvency II

ECB E.01.01 Deposits to cedants ECB Taxonomia 2.8.0 ECB E.02.01 Pension entitlements ECB Taxonomia 2.8.0 ECB E.04.01 Investment revenues and expenses ECB Taxonomia 2.8.0 ECB SE.01.01 Content of the submission ECB Taxonomia 2.8.0 ECB SE.02.01 Balance sheet ECB Taxonomia 2.8.0 ECB SE.06.02 List of assets ECB Taxonomia 2.8.0 S.01.01 Content of the submission EIOPA Grupo Taxonomia 2.8.0 S.01.01 Content of the submission EIOPA Individual Taxonomia 2.8.0 S.01.02 Basic information EIOPA Grupo Taxonomia 2.8.0 S.01.02 Basic information EIOPA Individual Taxonomia 2.8.0 S.01.03 Basic information — RFF and matching adjustment portfolios EIOPA Grupo Taxonomia 2.8.0 S.01.03 Basic Information — RFF and matching adjustment portfolios EIOPA Individual Taxonomia 2.8.0 S.02.01 Balance sheet EIOPA Grupo Taxonomia 2.8.0 S.02.01 Balance sheet EIOPA Individual Taxonomia 2.8.0 S.02.02 Liabilities by currency EIOPA Grupo Taxonomia 2.8.0 S.02.02 Liabilities by currency EIOPA Individual Taxonomia 2.8.0 S.03.01 Off-balance sheet items — General EIOPA Grupo Taxonomia 2.8.0 S.03.01 Off-balance sheet items — General EIOPA Individual Taxonomia 2.8.0 S.04.02 Information on class 10 in Part A of Annex I of Solvency II Directive, excluding carrier's liability EIOPA Individual Taxonomia 2.8.0 S.04.03 Basic Information – List of underwriting entities EIOPA Individual Taxonomia 2.8.0 S.04.04 Activity by country – location of underwriting EIOPA Individual Taxonomia 2.8.0 S.04.05 Activity by country – location of risk EIOPA Individual Taxonomia 2.8.0 S.05.01 Premiums, claims and expenses by line of business EIOPA Grupo Taxonomia 2.8.0 S.05.01 Premiums, claims and expenses by line of business EIOPA Individual Taxonomia 2.8.0 S.05.02 Premiums, claims and expenses by country EIOPA Grupo Taxonomia 2.8.0 S.06.02 List of assets EIOPA Grupo Taxonomia 2.8.0 S.06.02 List of assets EIOPA Individual Taxonomia 2.8.0 S.06.03 Collective investment undertakings — look-through approach EIOPA Grupo Taxonomia 2.8.0 S.06.03 Collective investment undertakings — look-through approach EIOPA Individual Taxonomia 2.8.0 S.06.04 Climate change-related risks to investments EIOPA Individual Taxonomia 2.8.0 S.07.01 Structured products EIOPA Grupo Taxonomia 2.8.0 S.07.01 Structured products EIOPA Individual Taxonomia 2.8.0 S.08.01 Open derivatives EIOPA Grupo Taxonomia 2.8.0 S.08.01 Open derivatives EIOPA Individual Taxonomia 2.8.0 S.09.01 Information on gains / income and losses in the period EIOPA Grupo Taxonomia 2.8.0 S.09.01 Information on gains/income and losses in the period EIOPA Individual Taxonomia 2.8.0 S.10.01 Securities lending and repos EIOPA Grupo Taxonomia 2.8.0 S.10.01 Securities lending and repos EIOPA Individual Taxonomia 2.8.0 S.11.01 Assets held as collateral EIOPA Grupo Taxonomia 2.8.0 S.11.01 Assets held as collateral EIOPA Individual Taxonomia 2.8.0 S.12.01 Life and Health SLT Technical Provisions EIOPA Individual Taxonomia 2.8.0 S.12.02 Life and Health SLT Technical Provisions — by Country EIOPA Individual Taxonomia 2.8.0 S.13.01 Projection of future gross cash flows (Best Estimate — Life) EIOPA Individual Taxonomia 2.8.0 S.14.01 Life obligations analysis EIOPA Individual Taxonomia 2.8.0 S.14.02 Non-Life obligation analysis EIOPA Individual Taxonomia 2.8.0 S.14.03 Cyber underwriting risk EIOPA Individual Taxonomia 2.8.0 S.16.01 Information on annuities stemming from Non-Life Insurance obligations EIOPA Individual Taxonomia 2.8.0 S.17.01 Non-life Technical Provisions EIOPA Individual Taxonomia 2.8.0 S.17.03 Non-Life Technical Provisions — By country EIOPA Individual Taxonomia 2.8.0 S.18.01 Projection of future cash flows (Best Estimate — Non Life) EIOPA Individual Taxonomia 2.8.0 S.19.01 Non-life insurance claims EIOPA Individual Taxonomia 2.8.0 S.20.01 Development of the distribution of the claims incurred EIOPA Individual Taxonomia 2.8.0 S.21.01 Loss distribution risk profile EIOPA Individual Taxonomia 2.8.0 S.21.02 Underwriting risks non-life EIOPA Individual Taxonomia 2.8.0 S.21.03 Non-life distribution of underwriting underwriting risks — by sum insured EIOPA Individual Taxonomia 2.8.0 S.22.01 Impact of long term guarantees measures and transitionals EIOPA Individual Taxonomia 2.8.0 S.22.01 Impact of long-term guarantees measures and transitionals EIOPA Grupo Taxonomia 2.8.0 S.22.02 Projection of future cash flows (Best Estimate — Matching portfolios) EIOPA Individual Taxonomia 2.8.0 S.22.03 Information on the matching adjustment calculation EIOPA Individual Taxonomia 2.8.0 S.22.04 Information on the transitional on interest rates calculation EIOPA Individual Taxonomia 2.8.0 S.22.05 Overall calculation of the transitional on technical provisions EIOPA Individual Taxonomia 2.8.0 S.22.06 Best estimate subject to volatility adjustment by country and currency EIOPA Individual Taxonomia 2.8.0 S.23.01 Own Funds EIOPA Grupo Taxonomia 2.8.0 S.23.01 Own Funds EIOPA Individual Taxonomia 2.8.0 S.23.02 Detailed information by tiers on own funds EIOPA Grupo Taxonomia 2.8.0 S.23.02 Detailed information by tiers on own funds EIOPA Individual Taxonomia 2.8.0 S.23.03 Annual movements on own funds EIOPA Grupo Taxonomia 2.8.0 S.23.03 Annual movements on own funds EIOPA Individual Taxonomia 2.8.0 S.23.04 List of items on own funds EIOPA Grupo Taxonomia 2.8.0 S.23.04 List of items on own funds EIOPA Individual Taxonomia 2.8.0 S.24.01 Participations held EIOPA Individual Taxonomia 2.8.0 S.25.01 Solvency Capital Requirement — for groups on Standard Formula EIOPA Grupo Taxonomia 2.8.0 S.25.01 Solvency Capital Requirement — for undertakings on Standard Formula EIOPA Individual Taxonomia 2.8.0 S.25.05 Solvency Capital Requirement - for groups using an internal model (partial or full) EIOPA Grupo Taxonomia 2.8.0 S.25.05 Solvency Capital Requirement — for undertakings using an internal model (partial or full) EIOPA Individual Taxonomia 2.8.0 S.26.01 Solvency Capital Requirement — Market risk EIOPA Grupo Taxonomia 2.8.0 S.26.01 Solvency Capital Requirement — Market risk EIOPA Individual Taxonomia 2.8.0 S.26.02 Solvency Capital Requirement — Counterparty default risk EIOPA Grupo Taxonomia 2.8.0 S.26.02 Solvency Capital Requirement — Counterparty default risk EIOPA Individual Taxonomia 2.8.0 S.26.03 Solvency Capital Requirements — Life underwriting risk EIOPA Grupo Taxonomia 2.8.0 S.26.03 Solvency Capital Requirements — Life underwriting risk EIOPA Individual Taxonomia 2.8.0 S.26.04 Solvency Capital Requirement — Health underwriting risk EIOPA Grupo Taxonomia 2.8.0 S.26.04 Solvency Capital Requirement — Health underwriting risk EIOPA Individual Taxonomia 2.8.0 S.26.05 Solvency Capital Requirement — Non-Life underwriting risk EIOPA Grupo Taxonomia 2.8.0 S.26.05 Solvency Capital Requirement — Non-Life underwriting risk EIOPA Individual Taxonomia 2.8.0 S.26.06 Solvency Capital Requirements — Operational risk EIOPA Grupo Taxonomia 2.8.0 S.26.06 Solvency Capital Requirements — Operational risk EIOPA Individual Taxonomia 2.8.0 S.26.07 Solvency Capital Requirement — Simplifications EIOPA Grupo Taxonomia 2.8.0 S.26.07 Solvency Capital Requirement — Simplifications EIOPA Individual Taxonomia 2.8.0 S.26.08 Solvency Capital Requirement - for groups using an internal model (partial or full) EIOPA Grupo Taxonomia 2.8.0 S.26.08 Solvency Capital Requirement — for undertakings using an internal model (partial or full) EIOPA Individual Taxonomia 2.8.0 S.26.09 Internal model: Market & Credit risk – for financial instruments EIOPA Grupo Taxonomia 2.8.0 S.26.09 Internal model: Market and Credit risk – for financial instruments EIOPA Individual Taxonomia 2.8.0 S.26.10 Internal model: Credit event risk – portfolio view details EIOPA Grupo Taxonomia 2.8.0 S.26.10 Internal model: Credit event risk – portfolio view details EIOPA Individual Taxonomia 2.8.0 S.26.11 Internal model: Credit risk – details for financial instruments EIOPA Grupo Taxonomia 2.8.0 S.26.11 Internal model: Credit risk – details for financial instruments EIOPA Individual Taxonomia 2.8.0 S.26.12 Internal model: Credit risk – for non-financial instruments EIOPA Grupo Taxonomia 2.8.0 S.26.12 Internal model: Credit risk – for non-financial instruments EIOPA Individual Taxonomia 2.8.0 S.26.13 Internal model: Non-Life & Health NSLT Underwriting risk EIOPA Grupo Taxonomia 2.8.0 S.26.13 Internal model: Non-Life & Health NSLT Underwriting risk EIOPA Individual Taxonomia 2.8.0 S.26.14 Internal model: Life and Health underwriting risk EIOPA Grupo Taxonomia 2.8.0 S.26.14 Internal model: Life and Health underwriting risk EIOPA Individual Taxonomia 2.8.0 S.26.15 Internal model: Operational risk EIOPA Grupo Taxonomia 2.8.0 S.26.15 Internal model: Operational risk EIOPA Individual Taxonomia 2.8.0 S.26.16 Internal model - Model Changes EIOPA Grupo Taxonomia 2.8.0 S.26.16 Internal model - Model Changes EIOPA Individual Taxonomia 2.8.0 S.27.01 Solvency Capital Requirement — Non-life and health catastrophe risk EIOPA Grupo Taxonomia 2.8.0 S.27.01 Solvency Capital Requirement — Non-life and health catastrophe risk EIOPA Individual Taxonomia 2.8.0 S.28.01 Minimum Capital Requirement — Only life or only non-life insurance or reinsurance activity EIOPA Individual Taxonomia 2.8.0 S.28.02 Minimum Capital Requirement — Both life and non-life insurance activity EIOPA Individual Taxonomia 2.8.0 S.29.01 Excess of Assets over Liabilities EIOPA Individual Taxonomia 2.8.0 S.29.02 Excess of Assets over Liabilities — explained by investments and financial liabilities EIOPA Individual Taxonomia 2.8.0 S.29.03 Excess of Assets over Liabilities — explained by technical provisions EIOPA Individual Taxonomia 2.8.0 S.29.04 Detailed analysis per period — Technical flows versus Technical provisions EIOPA Individual Taxonomia 2.8.0 S.30.01 Facultative covers for non-life and life business basic data EIOPA Individual Taxonomia 2.8.0 S.30.02 Facultative covers for non-life and life business shares data EIOPA Individual Taxonomia 2.8.0 S.30.03 Outgoing Reinsurance Program basic data EIOPA Individual Taxonomia 2.8.0 S.30.04 Outgoing Reinsurance Program shares data EIOPA Individual Taxonomia 2.8.0 S.31.01 Share of reinsurers (including Finite Reinsurance and SPV's) EIOPA Grupo Taxonomia 2.8.0 S.31.01 Share of reinsurers (including Finite Reinsurance and SPV's) EIOPA Individual Taxonomia 2.8.0 S.31.02 Special Purpose Vehicles EIOPA Grupo Taxonomia 2.8.0 S.31.02 Special Purpose Vehicles EIOPA Individual Taxonomia 2.8.0 S.32.01 Undertakings in the scope of the group EIOPA Grupo Taxonomia 2.8.0 S.33.01 Insurance and reinsurance individual requirements EIOPA Grupo Taxonomia 2.8.0 S.34.01 Other regulated and non-regulated financial undertakings including insurance holding companies and mixed financial holding companies EIOPA Grupo Taxonomia 2.8.0 S.35.01 Contribution to group Technical Provisions EIOPA Grupo Taxonomia 2.8.0 S.36.01 IGT — Equity-type transactions, debt and asset transfer EIOPA Grupo Taxonomia 2.8.0 S.36.01 IGT — Equity-type transactions, debt and asset transfer EIOPA Individual Taxonomia 2.8.0 S.36.02 IGT — Derivatives EIOPA Grupo Taxonomia 2.8.0 S.36.02 IGT — Derivatives EIOPA Individual Taxonomia 2.8.0 S.36.03 IGT — Off-balance sheet and contingent liabilities EIOPA Grupo Taxonomia 2.8.0 S.36.03 IGT — Off-balance sheet and contingent liabilities EIOPA Individual Taxonomia 2.8.0 S.36.04 IGT — Insurance and Reinsurance EIOPA Grupo Taxonomia 2.8.0 S.36.04 IGT — Insurance and Reinsurance EIOPA Individual Taxonomia 2.8.0 S.36.05 IGT — P&L EIOPA Grupo Taxonomia 2.8.0 S.36.05 IGT — Profit and Loss EIOPA Individual Taxonomia 2.8.0 S.36.06 IGT — Off-balance sheet and contingent liabilities EIOPA Individual Taxonomia 2.8.0 S.36.07 IGT — Insurance and Reinsurance EIOPA Individual Taxonomia 2.8.0 S.37.01 Risk concentration – Exposure to Counterparties EIOPA Grupo Taxonomia 2.8.0 S.37.02 Risk Concentration – Exposure by currency, sector, country EIOPA Grupo Taxonomia 2.8.0 S.37.03 Risk Concentration — Exposure by asset class and rating EIOPA Grupo Taxonomia 2.8.0

BOE Insurance

AoC.01 Analysis of Change in Solvency Capital Requirement BOE PS 15/24 · 2024 IM.00 Internal model risk output - Content of the submission and Basic information BOE PS 15/24 · 2024 IM.01 Internal model outputs (life) BOE PS 15/24 · 2024 IM.02 Internal model counterparty risk BOE PS 15/24 · 2024 IM.03 Internal model outputs (non-life) BOE PS 15/24 · 2024 IR.01.01 Content of the submission BOE PS 15/24 · 2024 IR.01.02 Basic information BOE PS 15/24 · 2024 IR.01.03 Basic information – RFF and matching adjustment portfolios BOE PS 15/24 · 2024 IR.01.04 Basic information – Branch legal entity BOE PS 15/24 · 2024 IR.02.01 Balance sheet BOE PS 15/24 · 2024 IR.02.02 Assets and liabilities by currency BOE PS 15/24 · 2024 IR.02.03 Additional branch balance sheet information BOE PS 15/24 · 2024 IR.03.01 Off-balance sheet items — general BOE PS 15/24 · 2024 IR.03.02 Off-balance sheet items —unlimited guarantees received BOE PS 15/24 · 2024 IR.03.03 Off-balance sheet items — unlimited guarantees provided BOE PS 15/24 · 2024 IR.05.02 Premiums, claims and expenses by country BOE PS 15/24 · 2024 IR.05.03 Life income and expenditure BOE PS 15/24 · 2024 IR.05.04 Non-life income, expenditure and business model analysis BOE PS 15/24 · 2024 IR.05.05 Life premiums and claims by country BOE PS 15/24 · 2024 IR.05.06 Non-life premiums and claims by country BOE PS 15/24 · 2024 IR.05.07 Business model analysis - financial guarantee insurers BOE PS 15/24 · 2024 IR.05.08 Material pooling arrangements BOE PS 15/24 · 2024 IR.05.09 Assessable mutuals BOE PS 15/24 · 2024 IR.05.10 .01 – Excess capital generation BOE PS 15/24 · 2024 IR.06.02 List of assets BOE PS 15/24 · 2024 IR.06.03 Collective investment undertakings — look-through approach BOE PS 15/24 · 2024 IR.08.01 Open derivatives BOE PS 15/24 · 2024 IR.09.01 Information on income/gains and losses in the period BOE PS 15/24 · 2024 IR.10.01 Securities lending and repos BOE PS 15/24 · 2024 IR.11.01 Assets held as collateral BOE PS 15/24 · 2024 IR.12.01 Life technical provisions BOE PS 15/24 · 2024 IR.12.03 Life best estimate liabilities by country BOE PS 15/24 · 2024 IR.12.04 best estimate assumptions for life insurance risks BOE PS 15/24 · 2024 IR.12.05 with-profits value of bonus BOE PS 15/24 · 2024 IR.12.06 with-profits liabilities and assets BOE PS 15/24 · 2024 IR.14.01 Life obligations analysis BOE PS 15/24 · 2024 IR.16.01 Non-life annuities information BOE PS 15/24 · 2024 IR.16.02 Non-life annuities projection of future cash flows BOE PS 15/24 · 2024 IR.17.01 Non-life technical provisions BOE PS 15/24 · 2024 IR.17.03 Non-life best estimate liabilities by country BOE PS 15/24 · 2024 IR.18.01 Non-life projection of future cash flows BOE PS 15/24 · 2024 IR.18.02 Non-life liability projection of future cash flows BOE PS 15/24 · 2024 IR.19.01 .01 — Non-life insurance claims BOE PS 15/24 · 2024 IR.19.02 Non-life general liability claim development BOE PS 15/24 · 2024 IR.20.01 Development of the distribution of the claims incurred BOE PS 15/24 · 2024 IR.21.02 .01 — Non-life underwriting risks BOE PS 15/24 · 2024 IR.21.04 Cyber underwriting risk BOE PS 15/24 · 2024 IR.22.01 Impact of long term guarantees measures and transitionals BOE PS 15/24 · 2024 IR.22.04 Information on the transitional on interest rates calculation BOE PS 15/24 · 2024 IR.22.07 Best estimate subject to volatility adjustment by currency BOE PS 15/24 · 2024 IR.23.01 Own Funds BOE PS 15/24 · 2024 IR.23.02 Detailed information by tiers on own funds BOE PS 15/24 · 2024 IR.23.03 Annual movements on own funds BOE PS 15/24 · 2024 IR.23.04 List of items on own funds BOE PS 15/24 · 2024 IR.23.05 Society of Lloyd’s own funds and capital requirements BOE PS 15/24 · 2024 IR.24.01 Participations held BOE PS 15/24 · 2024 IR.25.04 Solvency Capital Requirement BOE PS 15/24 · 2024 IR.25.05 Solvency Capital Requirement – Partial or full internal model components BOE PS 15/24 · 2024 IR.25.06 Solvency Capital Requirement – loss-absorbing capacity of deferred taxes BOE PS 15/24 · 2024 IR.26.01 Solvency Capital Requirement – Market risk BOE PS 15/24 · 2024 IR.26.02 Solvency Capital Requirement – Counterparty default risk BOE PS 15/24 · 2024 IR.26.03 Solvency Capital Requirement – Life underwriting risk BOE PS 15/24 · 2024 IR.26.04 Solvency Capital Requirement – Health underwriting risk BOE PS 15/24 · 2024 IR.26.05 Solvency Capital Requirement — Non-Life underwriting risk BOE PS 15/24 · 2024 IR.26.06 Solvency Capital Requirement — Operational risk BOE PS 15/24 · 2024 IR.26.07 Solvency Capital Requirement — Simplifications BOE PS 15/24 · 2024 IR.27.01 Solvency Capital Requirement — Non-life and health catastrophe risk BOE PS 15/24 · 2024 IR.28.01 .01 — Minimum Capital Requirement — Only life or only non-life activity BOE PS 15/24 · 2024 IR.28.02 .01 — Minimum Capital Requirement — Both life and non-life activity BOE PS 15/24 · 2024 IR.30.03 Non-life outwards reinsurance contract information BOE PS 15/24 · 2024 IR.30.04 Non-life outwards reinsurance contract reinsurer exposures BOE PS 15/24 · 2024 IR.30.05 Reinsurer and collateral provider entity information BOE PS 15/24 · 2024 IR.30.06 Life outwards reinsurance summary BOE PS 15/24 · 2024 IR.30.07 Life outwards proportional reinsurance BOE PS 15/24 · 2024 IR.30.08 Life outwards non-proportional reinsurance BOE PS 15/24 · 2024 IR.31.01 Outwards reinsurance balance sheet exposures BOE PS 15/24 · 2024 IR.32.01 Undertakings in the scope of the group BOE PS 15/24 · 2024 IR.33.01 Insurance and reinsurance individual requirements BOE PS 15/24 · 2024 IR.34.01 Other regulated and non-regulated financial undertakings BOE PS 15/24 · 2024 IR.35.01 Contribution to group technical provisions BOE PS 15/24 · 2024 IR.36.01 IGT — equity-type transactions, debt and asset transfer BOE PS 15/24 · 2024 IR.36.02 IGT — derivatives BOE PS 15/24 · 2024 IR.36.04 IGT — cost sharing, contingent liabilities, off BS and other items BOE PS 15/24 · 2024 IRR.22.02 Matching adjustment portfolio projection of future cash flows BOE PS 15/24 · 2024 IRR.22.03 Matching adjustment calculation BOE PS 15/24 · 2024 MALIR – Matching adjustment asset and liability information return: Content of the submission, basic information and analytical data BOE PS 15/24 · 2024 MR.01.02 Market risk sensitivities BOE PS 15/24 · 2024 QMC.01 Quarterly model change BOE PS 15/24 · 2024

Obtenha acesso ao Solvency II

E mantenha-se informado sobre as últimas atualizações, resultados financeiros e anúncios

Solicitar demo